Global Prader-Willi Syndrome Market Size, Share, and COVID-19 Impact Analysis, By Growth Hormone Therapy (Norditropin, Omnitrope, and Genotropin), By Hyperphagia Treatment (Carbetocin, ARD-101, and DCCR), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023-2033

Industry: Healthcare
RELEASE DATE Apr 2025
REPORT ID SI9642
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Growth Hormone Therapy
      2. Market Attractiveness Analysis By Hyperphagia Treatment
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising prevalence, awareness, and advanced therapies
    3. Restraints
      1.  High treatment costs and limited therapeutic options
    4. Opportunities
      1.  Rising awareness and innovative therapeutic developments globally
    5. Challenges
      1. limited accessibility and adoption globally
  6. Global Prader-Willi Syndrome Market Analysis and Projection, By Growth Hormone Therapy
    1. Segment Overview
    2. Norditropin
    3. Omnitrope
    4. Genotropin
  7. Global Prader-Willi Syndrome Market Analysis and Projection, By Hyperphagia Treatment
    1. Segment Overview
    2. Carbetocin
    3. ARD-101
    4. DCCR
  8. Global Prader-Willi Syndrome Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Prader-Willi Syndrome Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Prader-Willi Syndrome Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Sarepta Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Novartis 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Rhythm Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Kezar Life Sciences 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Axovant Gene Therapies 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Genentech
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Eli Lilly Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Newron Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Corcept Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Soleno Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Novo Nordisk
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  2. Global Norditropin, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  3. Global Omnitrope, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  4. Global Genotropin, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  5. Global Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  6. Global Carbetocin, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  7. Global ARD-101, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  8. Global DCCR, Prader-Willi Syndrome Market, By Region, 2024-2034(USD Billion)
  9. Global North America Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  10. North America Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  11. U.S.  Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  12. U.S.  Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  13. Canada Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  14. Canada Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  15. Mexico Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  16. Mexico Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  17. Europe Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  18. Europe Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  19. Germany Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  20. Germany Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  21. France Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  22. France Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  23. U.K.  Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  24. U.K.  Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  25. Italy Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  26. Italy Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  27. Spain Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  28. Spain Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  29. Asia Pacific Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  30. Asia Pacific Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  31. Japan Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  32. Japan Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  33. China Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  34. China Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  35. India Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  36. India Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  37. South America Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  38. South America Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  39. Brazil Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  40. Brazil Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  41. The Middle East and Africa Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD   Billion)
  42. The Middle East and Africa Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD   Billion)
  43. Billion)
  44. UAE Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  45. UAE Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)
  46. South Africa Prader-Willi Syndrome Market, By Growth Hormone Therapy, 2024-2034(USD Billion)
  47. South Africa Prader-Willi Syndrome Market, By Hyperphagia Treatment, 2024-2034(USD Billion)

 

List of Figures 

  1. Global Prader-Willi Syndrome Market Segmentation
  2. Prader-Willi Syndrome Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Prader-Willi Syndrome Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Prader-Willi Syndrome Market
  20. Prader-Willi Syndrome Market Segmentation, By Growth Hormone Therapy
  21. Prader-Willi Syndrome Market For Norditropin, By Region, 2024-2034 ($ Billion)
  22.  Prader-Willi Syndrome Market For Omnitrope, By Region, 2024-2034 ($ Billion)
  23. Prader-Willi Syndrome Market For Genotropin, By Region, 2024-2034 ($ Billion)
  24.  Prader-Willi Syndrome Market Segmentation, By Hyperphagia Treatment
  25.  Prader-Willi Syndrome Market For Carbetocin, By Region, 2024-2034 ($ Billion)
  26.  Prader-Willi Syndrome Market For ARD-101, By Region, 2024-2034 ($ Billion)
  27. Prader-Willi Syndrome Market For DCCR, By Region, 2024-2034 ($ Billion)
  28. Sarepta Therapeutics: Net Sales, 2024-2034 ($ Billion)
  29. Sarepta Therapeutics: Revenue Share, By Segment, 2024 (%)
  30. Sarepta Therapeutics: Revenue Share, By Region, 2024 (%)
  31. Novartis: Net Sales, 2024-2034 ($ Billion)
  32. Novartis: Revenue Share, By Segment, 2024 (%)
  33. Novartis: Revenue Share, By Region, 2024 (%)
  34. Rhythm Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  35. Rhythm Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  36. Rhythm Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  37. Kezar Life Sciences: Net Sales, 2024-2034 ($ Billion)
  38. Kezar Life Sciences: Revenue Share, By Segment, 2024 (%)
  39. Kezar Life Sciences: Revenue Share, By Region, 2024 (%)
  40. Axovant Gene Therapies: Net Sales, 2024-2034 ($ Billion)
  41. Axovant Gene Therapies: Revenue Share, By Segment, 2024 (%)
  42. Axovant Gene Therapies: Revenue Share, By Region, 2024 (%)
  43. Genentech: Net Sales, 2024-2034 ($ Billion)
  44. Genentech: Revenue Share, By Segment, 2024 (%)
  45. Genentech: Revenue Share, By Region, 2024 (%)
  46. Eli Lilly Company: Net Sales, 2024-2034 ($ Billion)
  47. Eli Lilly Company: Revenue Share, By Segment, 2024 (%)
  48. Eli Lilly Company: Revenue Share, By Region, 2024 (%)
  49. Newron Pharmaceuticals: Net Sales, 2024-2034 ($ Billion)
  50. Newron Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  51. Newron Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  52. Corcept Therapeutics.: Net Sales, 2024-2034 ($ Billion)
  53. Corcept Therapeutics.: Revenue Share, By Segment, 2024 (%)
  54. Corcept Therapeutics.: Revenue Share, By Region, 2024 (%)
  55. Soleno Therapeutics: Net Sales, 2024-2034 ($ Billion)
  56. Soleno Therapeutics: Revenue Share, By Segment, 2024 (%)
  57. Soleno Therapeutics: Revenue Share, By Region, 2024 (%)
  58. Novo Nordisk: Net Sales, 2024-2034 ($ Billion)
  59. Novo Nordisk: Revenue Share, By Segment, 2024 (%)
  60. Novo Nordisk: Revenue Share, By Region, 2024 (%)
  61. Others: Net Sales, 2024-2034 ($ Billion)
  62. Others: Revenue Share, By Segment, 2024 (%)
  63. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:130
Pages:240
Countries covered:17
Companies covered::20
Forecast CAGR:6.56%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies